RADICAVA 30 mg/100 mL
- Name: RADICAVA
- Generic Name: Edaravone
- Strength: single-dose vial.
- Manufactured: Mitsubishi Pharma Corporation
- Edaravone, sold under the brand name Radicava.
- This is an intravenous medication.
- It is used in order to help with the recovery following a stroke and to treat amyotrophic lateral sclerosis (ALS).
- The drug is basically an antioxidant, and oxidative stress has been hypothesized to be part of the process that kills neurons in patients with the Amyotrophic Lateral Sclerosis.
What is usually the first sign of ALS?
Amyotrophic Lateral Sclerosis is basically characterized by the muscle twitching, stiff muscles and gradually worsening weakness due to the muscles decreasing in size. It could begin with the weakness in the arms or legs, or with the difficulty speaking or swallowing.
How long can you live with ALS?
Death, usually from respiratory complications, typically comes between 3 and 5 years after diagnosis, but a significant number of those with the disease live more than 10 years, and some survive for decades. New therapies and technologies have contributed in order to the increase in the life expectancy for people with ALS, as well as their quality of life.
What are the 2 types of ALS?
Sporadic ALS is the most common form of ALS and second one is familial ALS, it basically runs in families.
What are the treatments for Amyotrophic Lateral Sclerosis (ALS)?
The treatment directly depends on the stage of the Amyotrophic Lateral Sclerosis. Drugs and therapies are able to slow down the ALS and also reduce the discomfort.
The U.S. FDA has approved the drug named edaravone (Radicava) to treat ALS. It is believed to be effective in order to treat ALS.
What is Radicava used for?
Radicava is a prescription medicine indicated to treat people with amyotrophic lateral sclerosis (ALS).
Does Radicava really work?
In May 2017, the FDA approved edaravone (Radicava, Mitsubishi Tanabe Pharma America), a novel neuroprotective agent, has the potential in order to slow down the advance of ALS.
What is the Generic Name for the trade name drug RADICAVA® ?
Edaravone injection is Generic Name for the trade name drug RADICAVA®
What is the Manufacturer Name of RADICAVA®?
RADICAVA® is manufactured by Mitsubishi Pharma Corporation
Is RADICAVA® approved by FDA?
Yes, RADICAVA® is approved by FDA. Date of approval: 2017
What is the dosage and form of RADICAVA® is available?
RADICAVA® is available as 30 mg/100 mL in a single-dose vial.
What is the Highlights of prescribing information of RADICAVA®?
Click Here to download full prescribing information
CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis. CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis.